News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
129 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
1 (166)
2 (102)
3 (83)
7 (129)
8 (150)
9 (151)
10 (125)
11 (80)
14 (124)
15 (127)
16 (162)
17 (157)
18 (97)
21 (128)
22 (162)
23 (135)
24 (201)
25 (112)
28 (144)
29 (147)
30 (202)
31 (200)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
7
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
31
Invitation To Lonza Group Ltd.’s Half Year Results 2014 Conference Call
July 7, 2014
·
1 min read
Genetown
Cellceutix Brilacidin ABSSSI Trial Gets Positive Review By Data Safety Monitoring Board; Best Possible Outcome, No Treatment-Related Serious Adverse Events (SAEs)
July 7, 2014
·
5 min read
OrthoSensor, Inc. Awarded Highest Honor In 2014 Best Of Sensors Expo
July 7, 2014
·
3 min read
Business
Portola Pharmaceuticals, Inc. Enters Into Clinical Collaboration Agreement With Daiichi Sankyo, Inc. For Phase 3 Studies Of Factor Xa Inhibitor Antidote, Andexanet Alfa, And Edoxaban
July 7, 2014
·
5 min read
Business
Immuron FY2014 Travelan® Sales Exceed $1 Million
July 7, 2014
·
1 min read
Phico Therapeutics Awarded Technology Strategy Board Biomedical Catalyst Grant To Develop Its SASPject Antibiotic Technology For Drug Resistant Bacteria
July 7, 2014
·
4 min read
FDA
BGI Diagnostics’ NIFTY Becomes First CFDA Approved Non-Invasive Prenatal Genetic Test
July 7, 2014
·
1 min read
Deals
Xellia Pharmaceuticals Expands Into The U.S. With Manufacturing Plant Buy
July 7, 2014
·
4 min read
FDA
FDA Approves Novo Nordisk A/S’s NovoSeven® RT To Treat Glanzmann’s Thrombasthenia (GT) With Refractoriness
July 7, 2014
·
5 min read
Drug Development
Endo International plc, BioDelivery Sciences International Painkiller BEMA® Buprenorphine Effective In Phase 3 Study
July 7, 2014
·
5 min read
Previous
12 of 13
Next